December 10, 2020 Sophia Vida
Biotech & Pharma

Immutep Explodes 190% on Positive Breast Cancer Treatment Trial Results

Shares of Australian biotech Immutep were soaring 190% on Thursday after Wall Street learned that the company had reported positive results from a trial of a treatment for metastatic breast cancer. Data was presented at the San Antonio Breast Cancer Symposium this week. According to the company’s overall survival data from the Phase 2b study … Continue reading “Immutep Explodes 190% on Positive Breast Cancer Treatment Trial Results”